Thousands of patients in England to get new hepatitis C drugs

BMJ 2015; 350 doi: (Published 12 June 2015) Cite this as: BMJ 2015;350:h3222
  1. Zosia Kmietowicz
  1. 1The BMJ

NHS England has announced that 3500 patients with liver cirrhosis from chronic infection with hepatitis C will have access to new drugs every year after new annual investment of £190m (€260m; $290m) to manage the disease.1

Currently only about 3% of patients with hepatitis C in the United Kingdom achieve a cure from hepatitis C infection because of low treatment rates and the low effectiveness of the previously available drugs.

But the crop of new drugs has brought in a new optimism in curing the disease. …

View Full Text

Sign in

Log in through your institution